India to Poland: Thalidomide Export Trade Route
India has recorded 26 verified shipments of Thalidomide exported to Poland, representing a combined trade value of $49.2K USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $1.9K USD. The leading Indian exporter is VAMA LIFECARE PRIVATE LIMITED, which accounts for 29% of total export value with 10 shipments worth $14.3K USD. On the buying side, EXP CODE is the largest importer in Poland with $10.6K USD in purchases. The top 3 suppliers — VAMA LIFECARE PRIVATE LIMITED, SARA INTERNATIONAL, ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED — together control 67% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Poland Thalidomide corridor is one of India's established pharmaceutical export routes, with 26 shipments documented worth a combined $49.2K USD. The route is dominated by VAMA LIFECARE PRIVATE LIMITED, which alone accounts for roughly 29% of all export value, reflecting the consolidated nature of India's thalidomide manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $1.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with thalidomide's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 17.9%, placing it at rank #5 among India's top thalidomide export destinations globally.
On the import side, key buyers of Indian thalidomide in Poland include EXP CODE, TO THE CONSIGNEE-, CONSIGNEE- BIALMED SP ZOO UL KAZIMIERZOWSKA and 8 others. EXP CODE is the single largest importer with 7 shipments valued at $10.6K USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ1
- Primary modeSea freight
- Top portBombay Air
Market Position
- Global rank#5
- Annual growth+17.9%
- Demand growth+17.3%
- Regulatory ease81/100
Top 10 Indian Thalidomide Exporters to Poland
Showing top 10 of 8 Indian suppliers exporting Thalidomide to Poland, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VAMA LIFECARE PRIVATE LIMITED Avg $1.4K per shipment | 10 | $14.3K | 29.1% |
| 2 | SARA INTERNATIONAL Avg $1.4K per shipment | 8 | $11.2K | 22.8% |
| 3 | ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED Avg $3.8K per shipment | 2 | $7.6K | 15.5% |
| 4 | ZYPHARS PHARMACEUTICS PVT LTD Avg $5.1K per shipment | 1 | $5.1K | 10.5% |
| 5 | SUNMOON CHEMICALS PRIVATE LIMITED Avg $4.0K per shipment | 1 | $4.0K | 8.1% |
| 6 | SUN MOON CHEMICALS PRIVATE LIMITED Avg $2.0K per shipment | 2 | $4.0K | 8.1% |
| 7 | SARA INTERNATIONAL Avg $2.8K per shipment | 1 | $2.8K | 5.6% |
| 8 | SACRED LEAVES PRIVATE LIMITED Avg $162 per shipment | 1 | $162 | 0.3% |
This table shows the top 10 of 8 Indian companies exporting thalidomide to Poland, ranked by total trade value. The listed exporters are: VAMA LIFECARE PRIVATE LIMITED, SARA INTERNATIONAL, ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED, ZYPHARS PHARMACEUTICS PVT LTD, SUNMOON CHEMICALS PRIVATE LIMITED, SUN MOON CHEMICALS PRIVATE LIMITED, SARA INTERNATIONAL , SACRED LEAVES PRIVATE LIMITED . VAMA LIFECARE PRIVATE LIMITED is the dominant supplier with 10 shipments worth $14.3K USD, giving it a 29% market share. The top 3 suppliers together account for 67% of the total trade value on this route.
Top 10 Thalidomide Importers in Poland
Showing top 10 of 11 known buyers in Poland receiving Thalidomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian thalidomide in Poland include EXP CODE, TO THE CONSIGNEE-, CONSIGNEE- BIALMED SP ZOO UL KAZIMIERZOWSKA, CONCERN PERSON SALUS INTERNATIONAL SP ZO O UL PULASKIEGO, TO THE ORDER OF CONCERN PERSON, among 11 total buyers. The largest importer is EXP CODE, accounting for $10.6K USD across 7 shipments — representing 22% of all thalidomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EXP CODE | 7 | $10.6K | 21.5% |
| 2 | TO THE CONSIGNEE- | 2 | $7.6K | 15.5% |
| 3 | CONSIGNEE- BIALMED SP ZOO UL KAZIMIERZOWSKA | 1 | $5.1K | 10.5% |
| 4 | CONCERN PERSON SALUS INTERNATIONAL SP ZO O UL PULASKIEGO | 4 | $4.5K | 9.2% |
| 5 | TO THE ORDER OF CONCERN PERSON | 3 | $4.2K | 8.6% |
| 6 | TO THE ORDER OF | 1 | $4.0K | 8.1% |
| 7 | GENESIS PHARMA | 2 | $4.0K | 8.1% |
| 8 | AS PER INVOICE POLAND | 3 | $3.7K | 7.6% |
| 9 | TO THE ORDER OF CONCERN PERSON | 1 | $2.8K | 5.6% |
| 10 | TO THE ORDEROF CONCERN PERSON | 1 | $2.4K | 4.9% |
Showing top 10 of 11 Thalidomide importers in Poland on this route.
Top 10 Thalidomide Formulations Imported by Poland
Showing top 10 of 19 product formulations shipped on the India to Poland Thalidomide route, ranked by trade value
Poland imports a wide range of thalidomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — HARMLESS MEDICINE FOR HUMAN CONSUMPTIONCAPS. THALIDOMIDE 100 MG CAPS. THALIVAX 100 MG BATCH NO. ABTMC2301YA MANUFACTURING — accounts for $5.6K USD across 3 shipments. There are 19 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HARMLESS MEDICINE FOR HUMAN CONSUMPTIONCAPS. THALIDOMIDE 100 MG CAPS. THALIVAX 100 MG BATCH NO. ABTMC2301YA MANUFACTURING | 3 | $5.6K | 11.5% |
| 2 | ASPER DOCUMENT NO: ZPPL/XP/2324/117 DATE:13/09/2023 SR NO. 5 THALIDOMIDE TABLETS100 MG | 1 | $5.1K | 10.5% |
| 3 | AS PER INVOICE NO:ZPPL/XP/2324/402 DATE:15.01.2024 SR NO:02 THALIDOMIDE TABLETS100 MGNOS | 1 | $4.3K | 8.6% |
| 4 | TAB. THALIPRIN 100MG(THALIDOMIDE) BATCHNO.TTMDB1303 MFG. DATE DEC-23 EXPIRY DATE NOV-25 | 1 | $4.0K | 8.1% |
| 5 | Tab.Thaliprin 100mgThalidomide | 2 | $4.0K | 8.1% |
| 6 | HARMLESS MEDICINE FOR HUMAN CONSUMPTIONCAPS. THALIDOMIDE 100 MG CAPS. THALIVAX 100 MG BATCH NO. ATMC2302YB MANUFACTURING D | 3 | $3.6K | 7.3% |
| 7 | ASPER INVOICE NO: ZPPL/XP/2324/477 DATE:07/03/2024 SR NO. 5 THALIDOMIDE TABLETS100 MG | 1 | $3.4K | 6.8% |
| 8 | THALIDOMIDE 100MG TAB. (30 TAB PER PACK) | 1 | $2.8K | 5.6% |
| 9 | PHARMACEUTICAL PRODUCT FOR HUMAN USE THALIDOMIDE 100MG TAB. 30 TAB PER PACK EACH FILM COATED TABLET CONTAINSTHALIDOM | 3 | $2.8K | 5.6% |
| 10 | PHARMACEUTICAL PRODUCT FOR HUMAN USE THALIDOMIDE 100MG TAB. (30 TAB PER PACK)(EACH FILM COATED TABLET CONTAINS : THALIDONOS | 1 | $2.4K | 4.9% |
Showing top 10 of 19 Thalidomide formulations imported by Poland on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
Bombay Air handles the highest volume with 11 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's thalidomide exports to Poland are driven primarily by a handful of large-scale manufacturers. VAMA LIFECARE PRIVATE LIMITED with 10 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — VAMA LIFECARE PRIVATE LIMITED, SARA INTERNATIONAL, ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED — together account for 67% of total trade value on this route. The average shipment value of $1.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as asper document no: zppl/xp/2324/117 date:13/09/2023 sr no. 5 thalidomide tablets100 mg and as per invoice no:zppl/xp/2324/402 date:15.01.2024 sr no:02 thalidomide tablets100 mgnos, suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EXP CODE is the largest importer with 7 shipments worth $10.6K USD — representing 22% of all thalidomide imports from India on this route. A total of 11 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $49.2K
- Avg. Shipment
- $1.9K
- Suppliers
- 8
- Buyers
- 11
- Transit (Sea)
- ~24 days
- Annual Growth
- +17.9%
Related Analysis
Other Thalidomide Routes
Unlock the Full India to Poland Thalidomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 26 shipments on this route.
Frequently Asked Questions — India to Poland Thalidomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Thalidomide to Poland?
The leading Indian exporters of Thalidomide to Poland are VAMA LIFECARE PRIVATE LIMITED, SARA INTERNATIONAL, ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED. VAMA LIFECARE PRIVATE LIMITED holds the largest market share at approximately 29% of total trade value on this route.
Q What is the total value of Thalidomide exports from India to Poland?
India exports Thalidomide to Poland worth approximately $49.2K USD across 26 recorded shipments. The average value per shipment is $1.9K USD.
Q Which ports does India use to ship Thalidomide to Poland?
The most active port of origin is Bombay Air with 11 shipments. Indian exporters primarily use sea freight for this route, with 78% of shipments going by sea and 25% by air.
Q How long does shipping take from India to Poland for Thalidomide?
The average transit time for Thalidomide shipments from India to Poland is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Poland Thalidomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 17.9% with demand growth tracking at 17.3%. The route is ranked #5 among India's top Thalidomide export destinations globally.
Q How many suppliers are active on the India to Poland Thalidomide route?
There are currently 8 active Indian suppliers exporting Thalidomide to Poland. The market is moderately concentrated with VAMA LIFECARE PRIVATE LIMITED accounting for 29% of total shipment value.
Q Who are the main importers of Thalidomide from India in Poland?
The leading importers of Indian Thalidomide in Poland include EXP CODE, TO THE CONSIGNEE-, CONSIGNEE- BIALMED SP ZOO UL KAZIMIERZOWSKA, CONCERN PERSON SALUS INTERNATIONAL SP ZO O UL PULASKIEGO, TO THE ORDER OF CONCERN PERSON. EXP CODE is the largest buyer with 7 shipments worth $10.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Poland export trade corridor identified from Indian Customs (DGFT) records for Thalidomide.
- 2.Supplier/Buyer Matching: 8 Indian exporters and 11 importers in Poland matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 26 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
26 Verified Shipments
8 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists